CWIG
TYRA icon

Chung Wu Investment Group’s Tyra Biosciences TYRA Stock Holding History

Chung Wu Investment Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.6K Hold
2,000
– – 0.07% 118
2025
Q4 		$52.6K Buy
+2,000
New +$36.7K 0.04% 134

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Chung Wu Investment Group's TYRA Position: Q1 2026 in Review

Chung Wu Investment Group held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 2,000 shares worth $76.6K. The position accounts for 0.07% of the portfolio, ranked #118.

Chung Wu Investment Group first reported a position in TYRA in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Chung Wu Investment Group held 2,000 shares of Tyra Biosciences worth $76.6K as of Q1 2026.
  • Chung Wu Investment Group left its Tyra Biosciences share count unchanged in Q1 2026.
  • Tyra Biosciences made up 0.07% of Chung Wu Investment Group's portfolio in Q1 2026, its #118 holding.
  • Chung Wu Investment Group first reported a position in Tyra Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Chung Wu Investment Group's 13F filing for Q1 2026, filed 12 May 2026.